Who
Jeffrey J. Kraws
Director
Company insider
Files Form 4 as: Director, Theriva Biologics; Co-President, Flyte Aviation; Director, Saleen Automotive.
In numbers
- Trades disclosed
- 31
- Buys
- 2
- Sells
- 2
- Bought
- $8,100
- Sold
- $90K
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 2 Nov 2007
- Last trade
- 5 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 6 Jan 2026 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 29 Apr 2025filed 1 May 2025 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 14 Dec 2023filed 15 Dec 2023 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 15 Dec 2022filed 16 Dec 2022 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 23 Dec 2021filed 27 Dec 2021 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 30 Dec 2020filed 31 Dec 2020 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 20 Nov 2020filed 24 Nov 2020 | VJET Flyte AviationMedical Devices | SEC FORM 4 Code A | $1,086200 at $5.43 | filing |
| 3 Aug 2020filed 5 Aug 2020 | VJET Flyte Aviationoption or derivative · Medical Devices | SEC FORM 4 Code P | —10,000 at $0.00 | filing |
| 3 Aug 2020filed 5 Aug 2020 | VJET Flyte AviationMedical Devices | SEC FORM 4 Bought | $3,50010,000 at $0.35 | filing |
| 22 May 2020filed 27 May 2020 | VJET Flyte AviationMedical Devices | SEC FORM 4 Bought | $4,60010,000 at $0.46 | filing |
| 20 Dec 2019filed 26 Dec 2019 | VJET Flyte AviationMedical Devices | SEC FORM 4 Code F | $713792 at $0.90 | filing |
| 4 Dec 2019filed 6 Dec 2019 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 4 Dec 2019filed 5 Dec 2019 | VJET Flyte AviationMedical Devices | SEC FORM 4 Code F | $70K38,372 at $1.82 | filing |
| 3 Dec 2019filed 5 Dec 2019 | VJET Flyte Aviationoption or derivative · Medical Devices | SEC FORM 4 Code A | —139,052 at $0.00 | filing |
| 18 Jul 2019filed 23 Jul 2019 | VJET Flyte AviationMedical Devices | SEC FORM 4 Sold | $35K11,930 at $2.93 | filing |
| 13 Jun 2019filed 17 Jun 2019 | VJET Flyte AviationMedical Devices | SEC FORM 4 Sold | $56K18,021 at $3.08 | filing |
| 6 Dec 2018filed 7 Dec 2018 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —79,500 at $0.00 | filing |
| 20 Dec 2017filed 21 Dec 2017 | TOVX Theriva Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 14 Mar 2017filed 16 Mar 2017 | TOVX Theriva BiologicsBiotechnology | SEC FORM 4 Code M | $21K228,773 at $0.09 | filing |
News
Flyte Aviation Establishes New B2B Distribution Channel, Launches Partner PortalVJET · manilatimes.net · 20 Oct 2026
0 headlines in the last 90 days name Jeffrey J. Kraws; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.